Abstract:BACKGROUND:The methylation inhibitor 5-Aza-2'-deoxycytidine (decitabine, DAC) has a great therapeutic value for acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). But decitabine monotherapy was associated with a relatively low rate of complete remission in AML and MDS. We aimed to investigate the effect of several anti-leukemia drugs in combination with decitabine on the proliferation of myeloid leukemia cells, to select the most efficient combination group and explore the associated mechanisms of these combination therapies.METHODS:Cell proliferation was tested by MTT assay and CFU-GM assay. Cell apoptosis was evaluated by Annexin V and PI staining in cell culture, TUNEL assay and transmission electron microscopy in animal study. MicroPET was used to imaging the tumor in mouse model. Molecular studies were conducted using microarray expression analysis, which was used to explore associated pathways, and real-time quantitative reverse transcription-PCR, western blot and immunohistochemistry, used to assess regulation of Wnt/β-catenin pathway. Statistical significance among groups was determined by one-way ANOVA analysis followed by post hoc Bonferroni's multiple comparison test.RESULTS:Among five anti-leukemia agents in combining with decitabine, the sequential combination of decitabine and idarubicin induced synergistic cell death in U937 cells, and this effect was verified in HEL, SKM-1 cells and AML cells isolated from AML patients. Importantly, tumor growth inhibition in this sequential combination was found to be higher than in single agent or controls in vivo. Moreover, sequential combination of the two agents induced apoptosis and depression of the Wnt/β-catenin pathway in both AML cell culture and animal studies.CONCLUSIONS:The findings demonstrated that sequentially combination of decitabine and idarubicin had synergistic anti-leukemia effects. These effects were mainly attributed to demethylation of Wnt/β-catenin pathway inhibitors and downregulation of Wnt/β-catenin pathway nuclear targets.

Vitamin C and MEK Inhibitor PD0325901 Synergistically Promote Oligodendrocytes Generation by Promoting DNA Demethylation

Sequential Combination of Decitabine and Idarubicin Synergistically Enhances Anti-Leukemia Effect Followed by Demethylating Wnt Pathway Inhibitor Promoters and Downregulating Wnt Pathway Nuclear Target

DNA methylation regulates the expression of the negative transcriptional regulators ID2 and ID4 during OPC differentiation

Trametinib, an anti-tumor drug, promotes oligodendrocytes generation and myelin formation

3039 – OXIDIZED 5-METHYLCYTOSINE MODULATES SYNTHETIC LETHALITY TO POLY-ADP-RIBOSE POLYMERASE INHIBITORS IN ACUTE MYELOID LEUKEMIA

Dynamics of Ten-Eleven Translocation Hydroxylase Family Proteins and 5-Hydroxymethylcytosine in Oligodendrocyte Differentiation

TET1-mediated Oligodendrocyte Homeostasis Regulates Myelination and Synaptic Functions

Role of Chromatin Remodeling Genes and TETs in the Development of Human Midbrain Dopaminergic Neurons.

Vitamin C Modulates TET1 Function During Somatic Cell Reprogramming.

Conversion of Mouse Fibroblasts into Oligodendrocyte Progenitor-Like Cells Through a Chemical Approach.

Combination Therapy With Fingolimod and Neural Stem Cells Promotes Functional Myelination in vivo Through a Non-immunomodulatory Mechanism

GSK3β Promotes the Differentiation of Oligodendrocyte Precursor Cells via β-Catenin-Mediated Transcriptional Regulation

Ectoderm Mesenchymal Stem Cells Promote Differentiation and Maturation of Oligodendrocyte Precursor Cells.

Epigenetic Reprogramming of Melanoma Cells by Vitamin C Treatment.

Cxcl12 Gene Engineered Endothelial Progenitor Cells Further Improve the Functions of Oligodendrocyte Precursor Cells

Inhibition of Tet1-and Tet2-mediated DNA Demethylation Promotes Immunomodulation of Periodontal Ligament Stem Cells

Vitamin C–dependent lysine demethylase 6 (KDM6)-mediated demethylation promotes a chromatin state that supports the endothelial-to-hematopoietic transition

9-cis-Retinoic Acid and 1,25-dihydroxy Vitamin D3 Improve the Differentiation of Neural Stem Cells into Oligodendrocytes through the Inhibition of the Notch and Wnt Signaling Pathways

Ten-eleven Translocation 1 Mediated-Dna Hydroxymethylation is Required for Myelination and Remyelination in the Mouse Brain

Inhibition of CXCR2 enhances CNS remyelination via modulating PDE10A/cAMP signaling pathway

N-Phenylquinazolin-2-amine Yhhu4952 As a Novel Promotor for Oligodendrocyte Differentiation and Myelination.